相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Free-water imaging in Parkinson's disease and atypical parkinsonism
Peggy J. Planetta et al.
BRAIN (2016)
Longitudinal changes in free-water within the substantia nigra of Parkinson's disease
Edward Ofori et al.
BRAIN (2015)
Distinct Patterns of Brain Activity in Progressive Supranuclear Palsy and Parkinson's Disease
Roxana G. Burciu et al.
MOVEMENT DISORDERS (2015)
Increased free water in the substantia nigra of Parkinson's disease: a single-site and multi-site study
Edward Ofori et al.
NEUROBIOLOGY OF AGING (2015)
Functional Brain Activity Relates to 0-3 and 3-8 Hz Force Oscillations in Essential Tremor
Kristina A. Neely et al.
CEREBRAL CORTEX (2015)
Distinct Functional and Macrostructural Brain Changes in Parkinson's Disease and Multiple System Atrophy
Peggy J. Planetta et al.
HUMAN BRAIN MAPPING (2015)
Functional neuroimaging of motor control in parkinson's disease: A meta-analysis
Damian M. Herz et al.
HUMAN BRAIN MAPPING (2014)
Disease duration and the integrity of the nigrostriatal system in Parkinson's disease
Jeffrey H. Kordower et al.
BRAIN (2013)
Levodopa changes brain motor network function during ankle movements in Parkinson's disease
Petra Schwingenschuh et al.
JOURNAL OF NEURAL TRANSMISSION (2013)
The Angular Gyrus: Multiple Functions and Multiple Subdivisions
Mohamed L. Seghier
NEUROSCIENTIST (2013)
Force Control Deficits in Individuals with Parkinson's Disease, Multiple Systems Atrophy, and Progressive Supranuclear Palsy
Kristina A. Neely et al.
PLOS ONE (2013)
Differences in Brain Activation Between Tremor- and Nontremor-Dominant Parkinson Disease
Janey Prodoehl et al.
JAMA NEUROLOGY (2013)
Levodopa influences striatal activity but does not affect cortical hyper-activity in Parkinson's disease
K. Martinu et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2012)
Effects of aging on the ventral and dorsal substantia nigra using diffusion tensor imaging
David E. Vaillancourt et al.
NEUROBIOLOGY OF AGING (2012)
Parkinson's Disease and Parkinsonism: Neuropathology
Dennis W. Dickson
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Quantification of increased cellularity during inflammatory demyelination
Yong Wang et al.
BRAIN (2011)
Current approaches to the treatment of Parkinson’s disease
Joseph Jankovic
Neuropsychiatric Disease and Treatment (2011)
Neural correlates of bimanual anti-phase and in-phase movements in Parkinson's disease
Tao Wu et al.
BRAIN (2010)
Basal Ganglia Hypoactivity During Grip Force in Drug Naive Parkinson's Disease
Matthew B. Spraker et al.
HUMAN BRAIN MAPPING (2010)
Blood Oxygenation Level-Dependent Activation in Basal Ganglia Nuclei Relates to Specific Symptoms in De Novo Parkinson's Disease
Janey Prodoehl et al.
MOVEMENT DISORDERS (2010)
Systematic Review of Levodopa Dose Equivalency Reporting in Parkinson's Disease
Claire L. Tomlinson et al.
MOVEMENT DISORDERS (2010)
Missing pieces in the Parkinson's disease puzzle
Jose A. Obeso et al.
NATURE MEDICINE (2010)
Pharmacology of Rasagiline, a New MAO-B Inhibitor Drug for the Treatment of Parkinson's Disease with Neuroprotective Potential
John P. M. Finberg
RAMBAM MAIMONIDES MEDICAL JOURNAL (2010)
Free Water Elimination and Mapping from Diffusion MRI
Ofer Pasternak et al.
MAGNETIC RESONANCE IN MEDICINE (2009)
A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
C. Warren Olanow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Levodopa-induced striatal activation in Parkinson's disease: A functional MRI study
Eduard Kraft et al.
PARKINSONISM & RELATED DISORDERS (2009)
Comparison of neuroprotective and neurorestorative capabilities of rasagiline and selegiline against lactacystin-induced nigrostriatal dopaminergic degeneration
Wen Zhu et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale Presentation and Clinimetric Testing Results
Christopher G. Goetz et al.
MOVEMENT DISORDERS (2008)
Region of interest template for the human basal ganglia: Comparing EPI and standardized space approaches
Janey Prodoehl et al.
NEUROIMAGE (2008)
Monoamine oxidase-B inhibition in the treatment of Parkinson's disease
Hubert H. Fernandez et al.
PHARMACOTHERAPY (2007)
Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease
Jack J. Chen et al.
CLINICAL THERAPEUTICS (2007)
The montreal cognitive assessment, MoCA:: A brief screening tool for mild cognitive impairment
ZS Nasreddine et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)
Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial
O Rascol et al.
LANCET (2005)
Neuroprotective effect of rasagiline in a rodent model of Parkinson's disease
F Blandini et al.
EXPERIMENTAL NEUROLOGY (2004)
Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain
N Tzourio-Mazoyer et al.
NEUROIMAGE (2002)
Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease
AJ Hughes et al.
NEUROLOGY (2001)
分享论文
